Zhang Kaiyue, Wang Chen, Wang Ran, Chen Shang, Li Zongjin
Nankai University School of Medicine.
State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University.
J Vis Exp. 2019 Aug 1(150). doi: 10.3791/59763.
Angiogenesis, as a crucial process of tumor progression, has become a research hotspot and target of anti-tumor therapy. However, there is no reliable model for tracing tumor progression and angiogenesis simultaneously in a visual and sensitive manner. Bioluminescence imaging displays its unique superiority in living imaging due to its advantages of high sensitivity, strong specificity, and accurate measurement. Presented here is a protocol to establish a tumor-bearing mouse model by injecting a Renilla luciferase-labeled murine breast cancer cell line 4T1 into the transgenic mouse with angiogenesis-induced Firefly luciferase expression. This mouse model provides a valuable tool to simultaneously monitor tumor progression and angiogenesis in real-time by dual bioluminescence imaging in a single mouse. This model may be widely applied in anti-tumor drug screening and oncology research.
血管生成作为肿瘤进展的关键过程,已成为研究热点和抗肿瘤治疗的靶点。然而,目前尚无可靠模型能以可视化且灵敏的方式同时追踪肿瘤进展和血管生成。生物发光成像因其具有高灵敏度、强特异性及测量准确等优势,在活体成像中展现出独特优越性。本文介绍一种通过将海肾荧光素酶标记的小鼠乳腺癌细胞系4T1注射到具有血管生成诱导型萤火虫荧光素酶表达的转基因小鼠体内来建立荷瘤小鼠模型的方案。该小鼠模型为在同一只小鼠中通过双生物发光成像实时同步监测肿瘤进展和血管生成提供了有价值的工具。此模型可能广泛应用于抗肿瘤药物筛选及肿瘤学研究。